Autoimmune pancreatitis: with special reference to a localized variant

Area of Science:

• Gastroenterology
• Immunology
• Radiology

Background:

• The 2006 Japan Pancreas Society revision clarified autoimmune pancreatitis (AIP) diagnostic criteria, encompassing morphological, pathological, and immunological features.
• While diagnostic criteria have improved, localized AIP can be mistaken for pancreatic cancer, posing a diagnostic challenge.

Purpose of the Study:

• To review the diagnostic criteria for autoimmune pancreatitis (AIP), focusing on differentiating localized AIP from pancreatic cancer.
• To highlight characteristic ultrasonographic findings and histological features crucial for accurate AIP diagnosis.

Main Methods:

• Review of revised diagnostic criteria for AIP, including imaging, serological markers (IgG4), and histopathology.
• Analysis of characteristic ultrasonographic findings in AIP, such as pancreatic enlargement, hypoechogenicity, and bile duct wall thickening.
• Evaluation of histological hallmarks like interlobular fibrosis, lymphoplasmacytic infiltration, and obliterative phlebitis.

Main Results:

• Revised criteria facilitate AIP diagnosis, with serum IgG4 levels being particularly informative.
• Localized AIP presents with focal mass formation in 24%-43% of cases and can be misdiagnosed as pancreatic cancer (72% of resected mass-forming pancreatitis cases).
• Characteristic ultrasonographic findings include pancreatic enlargement, hypoechogenicity, rarity of calcifications/cysts, thickened bile duct walls, and response to steroid therapy.

Conclusions:

• Accurate differentiation of localized AIP from pancreatic cancer is crucial, relying on characteristic imaging findings and histological verification.
• Contrast-enhanced endoscopic ultrasonography is valuable for differential diagnosis and assessing treatment response.
• Obliterative phlebitis and IgG4-positive plasma cells are highly specific histological markers for AIP.